Europe's Pharma Race: Red Tape vs Innovation

Roches CEO, Thomas Schinecker, warns Europe is falling behind the U.S. and China in pharmaceutical research due to excessive bureaucracy and policies. Trumps pricing rule has led to a significant drop in new drug launches. European leaders are sounding alarms, with AstraZenecas boss warning Germany could miss out on breakthrough drugs. Roche and Sanofi plan to launch new meds in Europe, but U.S. policies may impact their strategies. Europe is at a crossroads, facing the choice to fix red tape or watch innovation slip away. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/3becb5b1ea209440